Table 1

Demographic information and comorbidities stratified by COVID-19 status

COVID-19-negativeCOVID-19-positiveP value
Demographics
N2356
Age (mean±SD)65.7±18.262.5±15.20.42
Gender (% male)17 (73.9)37 (66.1)0.68
Ethnicity (%)0.65
 Black9 (39.1)25 (44.6)
 Caucasian13 (56.5)25 (44.6)
 Hispanic/Latino1 (4.3)4 (7.1)
 More than one0 (0)2 (3.6)
Alcohol use0.25
 None10 (43.5)34 (60.7)
 Moderate (<14 drinks/week)9 (39.1)18 (32.1)
 Excessive (>14 drinks/week)4 (17.4)4 (7.1)
Smoking0.001
 Never5 (21.7)29 (51.8)
 Former10 (43.5)24 (42.9)
 Active8 (34.8)3 (5.4)
Drug use (%)3 (13)8 (14.3)>0.99
Comorbidities (%)
Cardiovascular disease14 (60.9)25 (44.6)0.29
 CAD8 (34.8)10 (17.9)0.18
 HFrEF6 (26.1)9 (16.1)0.47
 HFpEF5 (21.7)6 (10.7)0.35
 Aortic valve disease4 (17.4)3 (5.4)0.20
 Mitral valve disease2 (8.7)4 (7.1)>0.99
 Atrial arrhythmias8 (34.8)12 (21.4)0.34
 Ventricular arrhythmias2 (8.7)2 (3.6)0.71
 PAD2 (8.7)4 (7.1)>0.99
 Aortopathy1 (4.3)1 (1.8)>0.99
Pulmonary disease8 (34.8)17 (30.4)0.91
Stroke4 (17.4)4 (7.1)0.33
Hypertension14 (60.9)37 (66.1)0.86
Diabetes5 (21.7)19 (33.9)0.42
Cancer history5 (21.7)9 (16.1)0.78
CKD5 (21.7)15 (26.8)0.85
Gastrointestinal disease6 (26.1)15 (26.8)>0.99
Neurological disease4 (17.4)6 (10.7)0.24
Psychiatric disease10 (43.5)11 (19.6)0.06
Sleep apnoea3 (13)11 (19.6)0.71
  • CAD, coronary artery disease; CKD, chronic kidney disease; HfpEF, heart failure with preserved ejection fraction; HfrEF, heart failure with reduced ejection fraction; PAD, peripheral arterial disease.